We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NTRA market cap is 22.05B. The company's latest EPS is USD -3.2934 and P/E is -50.94.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 268.31M | 311.11M | 367.74M | 413.35M | 439.76M |
| Operating Income | -110.98M | -84.54M | -74.31M | -43.9M | -39.34M |
| Net Income | -108.79M | -78.03M | -67.6M | -37.46M | -31.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 316.72M | 391.01M | 625.49M | 820.22M | 1.08B |
| Operating Income | -116.29M | -216.28M | -468.17M | -541.04M | -446.25M |
| Net Income | -124.83M | -229.74M | -471.72M | -547.8M | -434.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.45B | 1.44B | 1.47B | 1.52B | 1.59B |
| Total Liabilities | 661.86M | 676.37M | 674.09M | 680.47M | 712.42M |
| Total Equity | 784.66M | 765.33M | 794.11M | 836.52M | 878.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 582.66M | 932.15M | 1.24B | 1.39B | 1.44B |
| Total Liabilities | 303.95M | 445.92M | 583.18M | 688.73M | 676.37M |
| Total Equity | 278.71M | 486.24M | 653.3M | 705.74M | 765.33M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -188.83M | -246.96M | 27M | 30.99M | 82.78M |
| Investing | 143.83M | 168.5M | 138.26M | 106.2M | 148.74M |
| Financing | 247.62M | 254.46M | 6.47M | 17.51M | 19.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.44M | -182.51M | -335.24M | -431.5M | -246.96M |
| Investing | -266.35M | -331.46M | -205.19M | 330.34M | 168.5M |
| Financing | 340.77M | 500.85M | 576.19M | 482.64M | 254.46M |
| Market Cap | 22.05B |
| Price to Earnings Ratio | -50.94 |
| Price to Sales Ratio | 20.46 |
| Price to Cash Ratio | 34.49 |
| Price to Book Ratio | 28.94 |
| Dividend Yield | - |
| Shares Outstanding | 132.02M |
| Average Volume (1 week) | 747.86k |
| Average Volume (1 Month) | 1.06M |
| 52 Week Change | 172.65% |
| 52 Week High | 175.63 |
| 52 Week Low | 58.53 |
| Spread (Intraday) | 46 (26.9%) |
| Company Name | Natera Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.natera.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
